Compared with standard-risk (SR) B-ALL patients, those with high-risk (HR) disease had higher proportion of CD8+ T cells and lower proportion of CD4+ T cells (Figure 5A). This evidence concerns the gene CD8A and acute lymphoblastic leukemia.